NCT02766140 2019-01-18SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Terminated12 enrolled